文献速递产科母胎医学

脐-门-体静脉分流与宫内生长受限:一项前瞻性研究的探讨

Umbilical-portal-systemic venous shunt and intrauterine growth restriction: an inquiry from a prospective study.
PubMed 文献 · Am J Obstet Gynecol · 2024-01-12

前瞻性横断面研究纳入150例符合母胎医学会宫内生长受限指南的妊娠,用彩色多普勒筛查胎儿脐-门-体静脉分流,患病率9.3%(n=14)。合并分流者诊断孕周更早、分娩孕周更早、胎死率更高、活产率更低,且更常合并其他胎儿血管异常和静脉导管多普勒异常,子宫动脉多普勒异常更少。

要点

  • 宫内生长受限人群中脐-门-体静脉分流患病率为9.3%(n=14)。
  • 合并分流者胎死率21.4% vs 0.7%,活产率71.4% vs 95.6%。
  • 作者认为宫内生长受限产前评估可考虑细致超声检查门静脉系统。

核心结论

  • 脐-门-体静脉分流在生长受限胎儿中相对常见,合并该分流者多普勒血流模式不同、胎死风险升高、宫内生长受限表现更早、分娩孕周更低、更常合并其他先天血管异常,妊娠期高血压疾病发生率更低。
  • 作者认为宫内生长受限的产前评估可考虑细致超声检查门静脉系统,因脐-门-体静脉分流可能影响围产结局。

研究设计与样本

  • 前瞻性横断面研究,纳入150例按母胎医学会宫内生长受限指南诊断的妊娠。
  • 所有参与者接受详细畸形筛查并补充胎儿门静脉系统针对性扫描,以彩色多普勒诊断静脉分流。
  • 比较合并与不合并脐-门-体静脉分流的宫内生长受限妊娠的围产结局。

主要发现

  • 队列中脐-门-体静脉分流患病率为9.3%(n=14),对照组为不合并分流的宫内生长受限136例。
  • 研究组诊断宫内生长受限时平均孕周29.7±5.6周 vs 对照组32.47±4.6周(P=.036),分娩孕周33.50±6.0周 vs 36.13±2.8周(P=.005)。
  • 研究组胎死率21.4% vs 对照组0.7%(P<.001),活产率71.4% vs 95.6%(P=.001)。
  • 研究组其他相关胎儿血管异常35.7% vs 对照组4.4%(P≤.001),其他相关异常率相似。
  • 研究组子宫动脉多普勒异常0% vs 对照组40.4%(P=.011),静脉导管多普勒异常64.3% vs 23%(P=.001),妊娠期高血压疾病0例 vs 对照组12.5%(P=.16)。

关键数值与推荐

  • 宫内生长受限定义依据母胎医学会宫内生长受限指南。
  • 静脉分流以彩色多普勒模式诊断。
  • 其他围产与新生儿结局两组相当。

临床怎么用

  • 作者认为宫内生长受限的产前检查中可考虑对门静脉系统进行细致超声评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The investigation of the fetal umbilical-portal venous system is based on the premise that congenital anomalies of this system may be related to adverse perinatal outcomes. Several small retrospective studies have reported an association between umbilical-portal-systemic venous shunts and intrauterine growth restriction. However, the prevalence of portosystemic shunts in the fetal growth restricted population is yet to be determined. OBJECTIVE: The aims of this study were (1) to determine the prevalence of fetal umbilical-portal-systemic venous shunts in pregnancies complicated by intrauterine growth restriction and (2) to compare the perinatal and neonatal outcomes of pregnancies with intrauterine growth restriction with and without umbilical-portal-systemic venous shunts. STUDY DESIGN: This was a prospective, cross-sectional study of pregnancies diagnosed with intrauterine growth restriction, as defined by the Society for Maternal-Fetal Medicine intrauterine growth restriction guidelines. All participants underwent a detailed anomaly scan, supplemented with a targeted scan of the fetal portal system. Venous shunts were diagnosed using color Doppler mode. The perinatal outcomes of pregnancies with intrauterine growth restriction with and without umbilical-portal-systemic venous shunts were compared. RESULTS: A total of 150 cases with intrauterine growth restriction were recruited. The prevalence of umbilical-portal-systemic venous shunts in our cohort was 9.3% (n=14). When compared with the control group (intrauterine growth restriction without umbilical-portal-systemic venous shunts, n=136), the study group had a significantly lower mean gestational age at the time of intrauterine growth restriction diagnosis (29.7±5.6 vs 32.47±4.6 weeks of gestation; P=.036) and an earlier gestational age at delivery (33.50±6.0 vs 36.13±2.8; P=.005). The study group had a higher rate of fetal death (21.4% vs 0.7%; P<.001) and, accordingly, a lower rate of live births (71.4% vs 95.6%; P=.001). Additional associated fetal vascular anomalies were significantly more prevalent in the study group than in the control group (35.7% vs 4.4%; P≤.001). The rate of other associated anomalies was similar. The study group had a significantly lower rate of abnormal uterine artery Doppler indices (0% vs 40.4%; P=.011) and a higher rate of abnormal ductus venosus Doppler indices (64.3% vs 23%; P=.001). There were no cases of hypertensive disorders of pregnancy in the study group, whereas the control group had an incidence of 12.5% (P=.16). Other perinatal and neonatal outcomes were comparable. CONCLUSION: Umbilical-portal-systemic venous shunt is a relatively common finding among fetuses with growth restriction. When compared with pregnancies with intrauterine growth restriction with a normal portal system, these pregnancies complicated by intrauterine growth restriction and an umbilical-portal-systemic venous shunt are associated with a different Doppler flow pattern, an increased risk for fetal death, earlier presentation of intrauterine growth restriction, a lower gestational age at delivery, additional congenital vascular anomalies, and a lower rate of pregnancy-induced hypertensive disorders. Meticulous sonographic evaluation of the portal system should be considered in the prenatal workup of intrauterine growth restriction, as umbilical-portal-systemic venous shunts may affect perinatal outcomes.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Czeiger S, Weissbach T, Zloto K, et al. Umbilical-portal-systemic venous shunt and intrauterine growth restriction: an inquiry from a prospective study. Am J Obstet Gynecol. 2024. PMID: 38218510. doi:10.1016/j.ajog.2024.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。